Field | Row 1 |
---|---|
adsh | 0001654954-25-005754 |
cik | 1842566 |
name | AIRSHIP AI HOLDINGS, INC. |
sic | 7372 |
countryba | US |
stprba | WA |
cityba | REDMOND |
zipba | 98052 |
bas1 | 8210 154TH AVE NE |
bas2 | |
baph | (877) 462-4250 |
countryma | US |
stprma | WA |
cityma | REDMOND |
zipma | 98052 |
mas1 | 8210 154TH AVE NE |
mas2 | |
countryinc | US |
stprinc | DE |
ein | 934974766 |
former | BYTE ACQUISITION CORP. |
changed | 20210128 |
afs | 4-NON |
wksi | 0 |
fye | 1231 |
form | 10-Q |
period | 20250331 |
fy | 2025 |
fp | Q1 |
filed | 20250515 |
accepted | 2025-05-15 16:17:00.0 |
prevrpt | 0 |
detail | 1 |
instance | airsp_10q_htm.xml |
nciks | 1 |
aciks |
Field Name | Field Description |
---|---|
adsh | Accession Number. The 20-character string formed from the 18-digit number assigned by the SEC to each EDGAR submission. |
cik | Central Index Key (CIK). Ten digit number assigned by the SEC to each registrant that submits filings. |
name | Name of registrant. This corresponds to the name of the legal entity as recorded in EDGAR as of the filing date. |
sic | Standard Industrial Classification (SIC). Four digit code assigned by the SEC as of the filing date, indicating the registrant’s type of business. |
countryba | The ISO 3166-1 country of the registrant's business address. |
stprba | The state or province of the registrant’s business address, if field countryba is US or CA. |
cityba | The city of the registrant's business address. |
zipba | The zip code of the registrant’s business address. |
bas1 | The first line of the street of the registrant’s business address. |
bas2 | The second line of the street of the registrant’s business address. |
baph | The phone number of the registrant’s business address. |
countryma | The ISO 3166-1 country of the registrant's mailing address. |
stprma | The state or province of the registrant’s mailing address, if field countryma is US or CA. |
cityma | The city of the registrant's mailing address. |
zipma | The zip code of the registrant’s mailing address. |
mas1 | The first line of the street of the registrant’s mailing address. |
mas2 | The second line of the street of the registrant’s mailing address. |
countryinc | The ISO 3166-1 country of incorporation for the registrant. |
stprinc | The state or province of incorporation for the registrant, if countryinc is US or CA. |
ein | Employee Identification Number, 9 digit identification number assigned by the Internal Revenue Service to business entities operating in the United States. |
former | Most recent former name of the registrant, if any. |
changed | Date of change from the former name, if any. |
afs | Filer status with the SEC at the time of submission: 1-LAF=Large Accelerated, 2-ACC=Accelerated, 3-SRA=Smaller Reporting Accelerated, 4-NON=Non-Accelerated, 5-SML=Smaller Reporting Filer, NULL=not assigned. |
wksi | Well Known Seasoned Issuer (WKSI). An issuer that meets specific SEC requirements at some point during a 60-day period preceding the date the issuer satisfies its obligation to update its shelf registration statement. |
fye | Fiscal Year End Date, rounded to nearest month-end. |
form | The submission type of the registrant’s filing. |
period | Balance Sheet Date, rounded to nearest month-end. |
fy | Fiscal Year Focus (as defined in the EDGAR XBRL Guide Ch. 3.1.8). |
fp | Fiscal Period Focus (as defined in the EDGAR XBRL Guide Ch. 3.1.8) within Fiscal Year. |
filed | The date of the registrant’s filing with the Commission. |
accepted | The acceptance date and time of the registrant’s filing with the Commission. |
prevrpt | Previous Report – TRUE indicates that the submission information was subsequently amended. |
detail | TRUE indicates that the XBRL submission contains quantitative disclosures within the footnotes and schedules at the required detail level (e.g., each amount). |
instance | The name of the submitted XBRL Instance Document. The name often begins with the company ticker symbol. |
nciks | Number of Central Index Keys (CIK) of registrants (i.e., business units) included in the consolidating entity’s submitted filing. |
aciks | Additional CIKs of co-registrants included in a consolidating entity’s EDGAR submission, separated by spaces. If there are no other co-registrants (i.e., nciks=1), the value of aciks is NULL. For a very small number of filers, the entire list of co-registrants is too long to fit in the field. Where this is the case, users should refer to the complete submission file for all CIK information. |
adsh | ddate | tag | value | uom | qtrs | version | segments | coreg | footnote |
---|---|---|---|---|---|---|---|---|---|
0001654954-25-005754 | 20250331 | Earnings Per Share Diluted | 0.6100 | USD | 1 | us-gaap/2024 | |||
0001654954-25-005754 | 20250331 | Additional Paid In Capital | 27731753.0000 | USD | 0 | us-gaap/2024 | |||
0001654954-25-005754 | 20241231 | Allowance For Doubtful Accounts Receivable | 0.0000 | USD | 0 | us-gaap/2024 | |||
0001654954-25-005754 | 20241231 | Assets Current | 12659470.0000 | USD | 0 | us-gaap/2024 | |||
0001654954-25-005754 | 20250331 | Cash And Cash Equivalents At Carrying Value | 8812178.0000 | USD | 0 | us-gaap/2024 | |||
0001654954-25-005754 | 20250331 | Common Stock Par Or Stated Value Per Share | 3.2700 | USD | 0 | us-gaap/2024 | Plan Name= Employment Agreement; | ||
0001654954-25-005754 | 20250331 | Cost Of Goods And Services Sold | 2923087.0000 | USD | 1 | us-gaap/2024 | |||
0001654954-25-005754 | 20241231 | Deferred Revenue Current | 3238483.0000 | USD | 0 | us-gaap/2024 | |||
0001654954-25-005754 | 20240331 | Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | 3239.0000 | USD | 1 | us-gaap/2024 | |||
0001654954-25-005754 | 20240331 | Gross Profit | 2628127.0000 | USD | 1 | us-gaap/2024 | |||
0001654954-25-005754 | 20250331 | Income Tax Expense Benefit | 0.0000 | USD | 1 | us-gaap/2024 | |||
0001654954-25-005754 | 20240331 | Increase Decrease In Accounts Receivable | 55525.0000 | USD | 1 | us-gaap/2024 | |||
0001654954-25-005754 | 20240331 | Increase Decrease In Other Operating Assets | -1901.0000 | USD | 1 | us-gaap/2024 | |||
0001654954-25-005754 | 20240331 | Interest Income Expense Net | 31824.0000 | USD | 1 | us-gaap/2024 | |||
0001654954-25-005754 | 20240331 | Issuance Of Common Stock For Debt Conversion | 835610.0000 | USD | 1 | 0001654954-25-005754 | |||
0001654954-25-005754 | 20250331 | Issuance Of Common Stock For Earnout Shares Amount | 5282008.0000 | USD | 1 | 0001654954-25-005754 | Equity Components= Additional Paid In Capital; | ||
0001654954-25-005754 | 20250331 | Issuance Of Common Stock For Stock Options Exercise Amount | 43201.0000 | USD | 1 | 0001654954-25-005754 | |||
0001654954-25-005754 | 20250331 | Liabilities | 36440615.0000 | USD | 0 | us-gaap/2024 | |||
0001654954-25-005754 | 20240331 | Net Income Loss | -31964469.0000 | USD | 1 | us-gaap/2024 | |||
0001654954-25-005754 | 20250331 | Net Income Loss | 23707985.0000 | USD | 1 | us-gaap/2024 | |||
0001654954-25-005754 | 20241231 | Operating Lease Right Of Use Asset | 882024.0000 | USD | 0 | us-gaap/2024 | |||
0001654954-25-005754 | 20250331 | Other Assets | 165960.0000 | USD | 0 | us-gaap/2024 | |||
0001654954-25-005754 | 20250331 | Other Nonoperating Income Expense | 25422342.0000 | USD | 1 | us-gaap/2024 | |||
0001654954-25-005754 | 20250331 | Post Contract Support Cost Of Revenue | 312021.0000 | USD | 1 | 0001654954-25-005754 | |||
0001654954-25-005754 | 20241231 | Preferred Stock Value | 0.0000 | USD | 0 | us-gaap/2024 | |||
0001654954-25-005754 | 20241231 | Prepaid Expense And Other Assets Current | 17883.0000 | USD | 0 | us-gaap/2024 | |||
0001654954-25-005754 | 20240331 | Proceeds From Stock Options Exercised | 0.0000 | USD | 1 | us-gaap/2024 | |||
0001654954-25-005754 | 20240331 | Proceeds From Warrant Exercises | 293249.0000 | USD | 1 | us-gaap/2024 | |||
0001654954-25-005754 | 20250331 | Profit Loss | 23707985.0000 | USD | 1 | us-gaap/2024 | |||
0001654954-25-005754 | 20250331 | Recognition Of Right Of Use Asset | 304339.0000 | USD | 1 | 0001654954-25-005754 | |||
0001654954-25-005754 | 20240331 | Shares Issued | 23159119.0000 | shares | 0 | us-gaap/2024 | Equity Components= Common Stock Shares; | ||
0001654954-25-005754 | 20241231 | Shares Issued | 30588413.0000 | shares | 0 | us-gaap/2024 | Equity Components= Common Stock Shares; | ||
0001654954-25-005754 | 20240331 | Stockholders Equity | -48050609.0000 | USD | 0 | us-gaap/2024 | |||
0001654954-25-005754 | 20240331 | Stockholders Equity | -49441169.0000 | USD | 0 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
0001654954-25-005754 | 20241231 | Stockholders Equity | -74941590.0000 | USD | 0 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
0001654954-25-005754 | 20240331 | Stock Issued During Period Value Issued For Services | 0.0000 | USD | 1 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
0001654954-25-005754 | 20250331 | Accrued Liabilities Current | 60551.0000 | USD | 0 | us-gaap/2024 | |||
0001654954-25-005754 | 20241231 | Additional Paid In Capital | 21918867.0000 | USD | 0 | us-gaap/2024 | |||
0001654954-25-005754 | 20241231 | Advances From Founder | 1300000.0000 | USD | 0 | 0001654954-25-005754 | |||
0001654954-25-005754 | 20241231 | Assets | 13707454.0000 | USD | 0 | us-gaap/2024 | |||
0001654954-25-005754 | 20231231 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | 3124413.0000 | USD | 0 | us-gaap/2024 | |||
0001654954-25-005754 | 20240331 | Increase Decrease In Prepaid Expenses Other | -2010.0000 | USD | 1 | us-gaap/2024 | |||
0001654954-25-005754 | 20250331 | Cost Of Revenue | 3268024.0000 | USD | 1 | us-gaap/2024 | |||
0001654954-25-005754 | 20250331 | Increase Decrease In Income Taxes Receivable | 0.0000 | USD | 1 | us-gaap/2024 | |||
0001654954-25-005754 | 20241231 | Common Stock Shares Authorized | 200000000.0000 | shares | 0 | us-gaap/2024 | |||
0001654954-25-005754 | 20241231 | Earnout Liability | 23304808.0000 | USD | 0 | 0001654954-25-005754 | |||
0001654954-25-005754 | 20250331 | Earnout Liability | 8199079.0000 | USD | 0 | 0001654954-25-005754 | |||
0001654954-25-005754 | 20250331 | Earnout Liability | 0.0000 | USD | 0 | 0001654954-25-005754 | Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level2; | ||
0001654954-25-005754 | 20250331 | Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | -7409.0000 | USD | 1 | us-gaap/2024 | |||
0001654954-25-005754 | 20240331 | Foreign Currency Transaction Gain Loss Before Tax | 3239.0000 | USD | 1 | us-gaap/2024 | Equity Components= Accumulated Other Comprehensive Income; | ||
0001654954-25-005754 | 20250331 | Gain Loss From Change In Fair Value Of Convertible Note | 0.0000 | USD | 1 | 0001654954-25-005754 | |||
0001654954-25-005754 | 20250331 | Gross Profit | 2235004.0000 | USD | 1 | us-gaap/2024 | |||
0001654954-25-005754 | 20250331 | Income Loss From Subsidiaries Before Tax | 23707985.0000 | USD | 1 | us-gaap/2024 | |||
0001654954-25-005754 | 20250331 | Issuance Of Common Stock For Earnout Shares Shares | 1160906.0000 | shares | 1 | 0001654954-25-005754 | Equity Components= Common Stock Shares; | ||
0001654954-25-005754 | 20240331 | Issuance Of Common Stock For Exercise Of Warrants Value | 16.0000 | USD | 1 | 0001654954-25-005754 | Equity Components= Common Stock Shares; | ||
0001654954-25-005754 | 20250331 | Issuance Of Common Stock For Stock Options Exercise Amount | 0.0000 | USD | 1 | 0001654954-25-005754 | Equity Components= Retained Earnings; | ||
0001654954-25-005754 | 20241231 | Liabilities | 66730591.0000 | USD | 0 | us-gaap/2024 | |||
0001654954-25-005754 | 20240331 | Net Income Loss | 0.0000 | USD | 1 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
0001654954-25-005754 | 20240331 | Operating Income Loss | -1402533.0000 | USD | 1 | us-gaap/2024 | |||
0001654954-25-005754 | 20250331 | Other Services Revenue | 7737.0000 | shares | 1 | 0001654954-25-005754 | |||
0001654954-25-005754 | 20240331 | Recognition Of Operating Lease Liability | 0.0000 | USD | 1 | 0001654954-25-005754 | |||
0001654954-25-005754 | 20250331 | Recognition Of Operating Lease Liability | 304339.0000 | USD | 1 | 0001654954-25-005754 | |||
0001654954-25-005754 | 20240331 | Recognition Of Right Of Use Asset | 0.0000 | USD | 1 | 0001654954-25-005754 | |||
0001654954-25-005754 | 20250331 | Research And Development Expense | 719382.0000 | USD | 1 | us-gaap/2024 | |||
0001654954-25-005754 | 20250331 | Revenues | 4500000.0000 | USD | 1 | us-gaap/2024 | Timing Of Transfer Of Good Or Service= Transferred At Point In Time; | ||
0001654954-25-005754 | 20250331 | Share Based Compensation | 428286.0000 | USD | 1 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
0001654954-25-005754 | 20250331 | Share Based Compensation | 294525.0000 | USD | 1 | us-gaap/2024 | Plan Name= Stock Incentive Plan; | ||
0001654954-25-005754 | 20240331 | Stockholders Equity | 2314.0000 | USD | 0 | us-gaap/2024 | Equity Components= Common Stock Shares; | ||
0001654954-25-005754 | 20240331 | Stock Issued During Period Value Conversion Of Units | 17.0000 | USD | 1 | us-gaap/2024 | Equity Components= Common Stock Shares; | ||
0001654954-25-005754 | 20240331 | Stock Issued During Period Value Issued For Services | 0.0000 | USD | 1 | us-gaap/2024 | Equity Components= Common Stock Shares; | ||
0001654954-25-005754 | 20250331 | Accounts Receivable Net | 2782650.0000 | USD | 0 | us-gaap/2024 | |||
0001654954-25-005754 | 20250331 | Allowance For Doubtful Accounts Receivable | 0.0000 | USD | 0 | us-gaap/2024 | |||
0001654954-25-005754 | 20250331 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | 8812178.0000 | USD | 0 | us-gaap/2024 | |||
0001654954-25-005754 | 20250331 | Common Stock Par Or Stated Value Per Share | 0.0001 | USD | 0 | us-gaap/2024 | |||
0001654954-25-005754 | 20240331 | Comprehensive Income Net Of Tax | -31961230.0000 | USD | 1 | us-gaap/2024 | |||
0001654954-25-005754 | 20240331 | Cost Of Revenue | 7946888.0000 | USD | 1 | us-gaap/2024 | |||
0001654954-25-005754 | 20240331 | Earnings Per Share Basic | -1.4000 | USD | 1 | us-gaap/2024 | |||
0001654954-25-005754 | 20241231 | Earnout Liability | 15479808.0000 | USD | 0 | 0001654954-25-005754 | Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level3; | ||
0001654954-25-005754 | 20250331 | Foreign Currency Transaction Gain Loss Before Tax | -7409.0000 | USD | 1 | us-gaap/2024 | Equity Components= Accumulated Other Comprehensive Income; | ||
0001654954-25-005754 | 20250331 | Foreign Currency Transaction Gain Loss Before Tax | 0.0000 | USD | 1 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
0001654954-25-005754 | 20250331 | Gain Loss From Change In Fair Value Of Earnout Liability | 9823605.0000 | USD | 1 | 0001654954-25-005754 | |||
0001654954-25-005754 | 20250331 | Guaranty Liabilities | 18659435.0000 | USD | 0 | us-gaap/2024 | |||
0001654954-25-005754 | 20240331 | Income Loss From Subsidiaries Before Tax | -31964469.0000 | USD | 1 | us-gaap/2024 | |||
0001654954-25-005754 | 20240331 | Income Tax Expense Benefit | 0.0000 | USD | 1 | us-gaap/2024 | |||
0001654954-25-005754 | 20250331 | Increase Decrease In Other Operating Assets | 0.0000 | USD | 1 | us-gaap/2024 | |||
0001654954-25-005754 | 20250331 | Increase Decrease In Prepaid Expenses Other | 49428.0000 | USD | 1 | us-gaap/2024 | |||
0001654954-25-005754 | 20240331 | Interest Paid Net | 0.0000 | USD | 1 | us-gaap/2024 | |||
0001654954-25-005754 | 20250331 | Issuance Of Common Stock For Earnout Shares Amount | 0.0000 | USD | 1 | 0001654954-25-005754 | Equity Components= Retained Earnings; | ||
0001654954-25-005754 | 20250331 | Issuance Of Common Stock For Exercise Of Warrants Shares | 13200.0000 | shares | 1 | 0001654954-25-005754 | Equity Components= Common Stock Shares; | ||
0001654954-25-005754 | 20240331 | Issuance Of Common Stock For Exercise Of Warrants Value | 0.0000 | USD | 1 | 0001654954-25-005754 | Equity Components= Accumulated Other Comprehensive Income; | ||
0001654954-25-005754 | 20250331 | Issuance Of Common Stock For Exercise Of Warrants Value | 0.0000 | USD | 1 | 0001654954-25-005754 | Equity Components= Retained Earnings; | ||
0001654954-25-005754 | 20250331 | Issuance Of Common Stock For Stock Options Exercise Amount | 0.0000 | USD | 1 | 0001654954-25-005754 | Equity Components= Accumulated Other Comprehensive Income; | ||
0001654954-25-005754 | 20241231 | Liabilities And Stockholders Equity | 13707454.0000 | USD | 0 | us-gaap/2024 | |||
0001654954-25-005754 | 20240331 | Operating Expenses | 4030660.0000 | USD | 1 | us-gaap/2024 | |||
0001654954-25-005754 | 20250331 | Operating Income Loss | -1714357.0000 | USD | 1 | us-gaap/2024 | |||
0001654954-25-005754 | 20250331 | Post Contract Support Revenue | 998051.0000 | USD | 1 | 0001654954-25-005754 | |||
0001654954-25-005754 | 20241231 | Preferred Stock No Par Value | 0.0000 | USD | 0 | us-gaap/2024 | |||
0001654954-25-005754 | 20250331 | Preferred Stock Shares Authorized | 5000000.0000 | shares | 0 | us-gaap/2024 | |||
0001654954-25-005754 | 20250331 | Preferred Stock Value | 0.0000 | USD | 0 | us-gaap/2024 | |||
0001654954-25-005754 | 20250331 | Proceeds From Warrant Exercises | 59400.0000 | USD | 1 | us-gaap/2024 | |||
0001654954-25-005754 | 20240331 | Product Revenue | 9398776.0000 | USD | 1 | 0001654954-25-005754 | |||
0001654954-25-005754 | 20250331 | Product Revenue | 4497240.0000 | USD | 1 | 0001654954-25-005754 | |||
0001654954-25-005754 | 20241231 | Retained Earnings Accumulated Deficit | -74941590.0000 | USD | 0 | us-gaap/2024 | |||
0001654954-25-005754 | 20250331 | Revenues | 5503028.0000 | USD | 1 | us-gaap/2024 | |||
0001654954-25-005754 | 20250331 | Revenues | 1000000.0000 | USD | 1 | us-gaap/2024 | Timing Of Transfer Of Good Or Service= Transferred Over Time; | ||
0001654954-25-005754 | 20240331 | Share Based Compensation | 0.0000 | USD | 1 | us-gaap/2024 | Equity Components= Common Stock Shares; | ||
0001654954-25-005754 | 20250331 | Share Based Compensation | 131000.0000 | USD | 1 | us-gaap/2024 | Title Of Individual= Mr Allen; | ||
0001654954-25-005754 | 20240331 | Stockholders Equity | 1397815.0000 | USD | 0 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
0001654954-25-005754 | 20241231 | Stockholders Equity | -3470.0000 | USD | 0 | us-gaap/2024 | Equity Components= Accumulated Other Comprehensive Income; | ||
0001654954-25-005754 | 20250331 | Stockholders Equity | -10879.0000 | USD | 0 | us-gaap/2024 | Equity Components= Accumulated Other Comprehensive Income; | ||
0001654954-25-005754 | 20240331 | Stock Issued During Period Value Issued For Services | 0.0000 | USD | 1 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
0001654954-25-005754 | 20240331 | Weighted Average Number Of Diluted Shares Outstanding | 22898487.0000 | shares | 1 | us-gaap/2024 | |||
0001654954-25-005754 | 20250331 | Weighted Average Number Of Diluted Shares Outstanding | 38820839.0000 | shares | 1 | us-gaap/2024 | |||
0001654954-25-005754 | 20250331 | Advances From Founder | 700000.0000 | USD | 0 | 0001654954-25-005754 | |||
0001654954-25-005754 | 20250331 | Assets Current | 11662139.0000 | USD | 0 | us-gaap/2024 | |||
0001654954-25-005754 | 20240331 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect | -1401835.0000 | USD | 1 | us-gaap/2024 | |||
0001654954-25-005754 | 20241231 | Common Stock Par Or Stated Value Per Share | 0.0001 | USD | 0 | us-gaap/2024 | |||
0001654954-25-005754 | 20250331 | Common Stock Shares Authorized | 200000000.0000 | shares | 0 | us-gaap/2024 | |||
0001654954-25-005754 | 20250331 | Deferred Revenue Current | 2948695.0000 | USD | 0 | us-gaap/2024 | |||
0001654954-25-005754 | 20250331 | Deferred Revenue Current | 2948695.0000 | USD | 0 | us-gaap/2024 | Deferred Revenue Arrangement Type= Revenues; | ||
0001654954-25-005754 | 20240331 | Depreciation And Amortization | 1861.0000 | USD | 1 | us-gaap/2024 | |||
0001654954-25-005754 | 20250331 | Depreciation And Amortization | 0.0000 | USD | 1 | us-gaap/2024 | |||
0001654954-25-005754 | 20240331 | Earnings Per Share Diluted | -1.4000 | USD | 1 | us-gaap/2024 | |||
0001654954-25-005754 | 20241231 | Earnout Liability | 0.0000 | USD | 0 | 0001654954-25-005754 | Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level2; | ||
0001654954-25-005754 | 20240331 | Foreign Currency Transaction Gain Loss Before Tax | 0.0000 | USD | 1 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
0001654954-25-005754 | 20250331 | Foreign Currency Transaction Gain Loss Before Tax | 0.0000 | USD | 1 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
0001654954-25-005754 | 20240331 | Gain Loss From Change In Fair Value Of Convertible Note | -2039377.0000 | USD | 1 | 0001654954-25-005754 | |||
0001654954-25-005754 | 20240331 | Gain Loss On Note Conversions | -158794.0000 | USD | 1 | 0001654954-25-005754 | |||
0001654954-25-005754 | 20250331 | Interest Income Expense Net | -77554.0000 | USD | 1 | us-gaap/2024 | |||
0001654954-25-005754 | 20250331 | Issuance Of Common Stock For Earnout Shares Amount | 5282125.0000 | USD | 1 | 0001654954-25-005754 | |||
0001654954-25-005754 | 20250331 | Issuance Of Common Stock For Exercise Of Warrants Value | 59400.0000 | USD | 1 | 0001654954-25-005754 | |||
0001654954-25-005754 | 20250331 | Issuance Of Common Stock For Stock Options Exercise Amount | 43193.0000 | USD | 1 | 0001654954-25-005754 | Equity Components= Additional Paid In Capital; | ||
0001654954-25-005754 | 20240331 | Net Income Loss | -31964469.0000 | USD | 1 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
0001654954-25-005754 | 20250331 | Net Income Loss | 23707985.0000 | USD | 1 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
0001654954-25-005754 | 20240331 | Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax | 3239.0000 | USD | 1 | us-gaap/2024 | |||
0001654954-25-005754 | 20240331 | Other Nonoperating Income Expense | -30561936.0000 | USD | 1 | us-gaap/2024 | |||
0001654954-25-005754 | 20240331 | Other Restructuring Costs | 0.0000 | USD | 1 | us-gaap/2024 | |||
0001654954-25-005754 | 20240331 | Repayments Of Related Party Debt | 0.0000 | USD | 1 | us-gaap/2024 | |||
0001654954-25-005754 | 20250331 | Repayments Of Related Party Debt | 600000.0000 | USD | 1 | us-gaap/2024 | |||
0001654954-25-005754 | 20240331 | Research And Development Expense | 695366.0000 | USD | 1 | us-gaap/2024 | Related Party Transactions By Related Party= One Year Support Contracts; | ||
0001654954-25-005754 | 20240331 | Selling General And Administrative Expense | 3335294.0000 | USD | 1 | us-gaap/2024 | |||
0001654954-25-005754 | 20231231 | Shares Issued | 22812048.0000 | shares | 0 | us-gaap/2024 | Equity Components= Common Stock Shares; | ||
0001654954-25-005754 | 20240229 | Shares Issued | 169204.0000 | shares | 0 | us-gaap/2024 | Debt Instrument= Platinum Capital Partner Inc; | ||
0001654954-25-005754 | 20250331 | Shares Issued | 31844471.0000 | shares | 0 | us-gaap/2024 | Equity Components= Common Stock Shares; | ||
0001654954-25-005754 | 20231231 | Stockholders Equity | 2281.0000 | USD | 0 | us-gaap/2024 | Equity Components= Common Stock Shares; | ||
0001654954-25-005754 | 20250331 | Stockholders Equity | -23509549.0000 | USD | 0 | us-gaap/2024 | |||
0001654954-25-005754 | 20250331 | Stockholders Equity | 3182.0000 | USD | 0 | us-gaap/2024 | Equity Components= Common Stock Shares; | ||
0001654954-25-005754 | 20250331 | Stockholders Equity | -51233605.0000 | USD | 0 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
0001654954-25-005754 | 20240331 | Stock Issued During Period Shares Conversion Of Units | 169204.0000 | shares | 1 | us-gaap/2024 | Equity Components= Common Stock Shares; | ||
0001654954-25-005754 | 20240331 | Stock Issued During Period Value Conversion Of Units | 835593.0000 | USD | 1 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
0001654954-25-005754 | 20240331 | Stock Issued During Period Value Issued For Services | 0.0000 | USD | 1 | us-gaap/2024 | |||
0001654954-25-005754 | 20250331 | Weighted Average Number Of Shares Issued Basic | 31704117.0000 | shares | 1 | us-gaap/2024 | |||
0001654954-25-005754 | 20250331 | Foreign Currency Transaction Gain Loss Before Tax | 0.0000 | USD | 1 | us-gaap/2024 | Equity Components= Common Stock Shares; | ||
0001654954-25-005754 | 20250331 | Gain Loss On Note Conversions | 0.0000 | USD | 1 | 0001654954-25-005754 | |||
0001654954-25-005754 | 20240331 | Increase Decrease In Deferred Revenue | -924048.0000 | USD | 1 | us-gaap/2024 | |||
0001654954-25-005754 | 20240331 | Increase Decrease In Income Taxes Receivable | 2410.0000 | USD | 1 | us-gaap/2024 | |||
0001654954-25-005754 | 20250331 | Increase Decrease In Operating Lease Liability | -83750.0000 | USD | 1 | us-gaap/2024 | |||
0001654954-25-005754 | 20250331 | Issuance Of Common Stock For Earnout Shares | 5282125.0000 | USD | 1 | 0001654954-25-005754 | |||
0001654954-25-005754 | 20250331 | Issuance Of Common Stock For Exercise Of Warrants Value | 59399.0000 | USD | 1 | 0001654954-25-005754 | Equity Components= Additional Paid In Capital; | ||
0001654954-25-005754 | 20250331 | Liabilities Current | 6295009.0000 | USD | 0 | us-gaap/2024 | |||
0001654954-25-005754 | 20240331 | Net Cash Provided By Used In Financing Activities | 293249.0000 | USD | 1 | us-gaap/2024 | |||
0001654954-25-005754 | 20250331 | Net Income Loss | 0.0000 | USD | 1 | us-gaap/2024 | Equity Components= Accumulated Other Comprehensive Income; | ||
0001654954-25-005754 | 20250331 | Operating Expenses | 3949361.0000 | USD | 1 | us-gaap/2024 | |||
0001654954-25-005754 | 20241231 | Operating Lease Liability Current | 305178.0000 | USD | 0 | us-gaap/2024 | |||
0001654954-25-005754 | 20241231 | Other Assets | 165960.0000 | USD | 0 | us-gaap/2024 | |||
0001654954-25-005754 | 20250331 | Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax | -7409.0000 | USD | 1 | us-gaap/2024 | |||
0001654954-25-005754 | 20250331 | Preferred Stock Shares Outstanding | 0.0000 | shares | 0 | us-gaap/2024 | |||
0001654954-25-005754 | 20250331 | Proceed From Convertible Debt | 0.0000 | USD | 1 | 0001654954-25-005754 | |||
0001654954-25-005754 | 20240331 | Research And Development Expense | 695366.0000 | USD | 1 | us-gaap/2024 | |||
0001654954-25-005754 | 20240331 | Share Based Compensation | 268989.0000 | USD | 1 | us-gaap/2024 | |||
0001654954-25-005754 | 20240331 | Share Based Compensation | 0.0000 | USD | 1 | us-gaap/2024 | Equity Components= Accumulated Other Comprehensive Income; | ||
0001654954-25-005754 | 20240331 | Share Based Compensation | 268989.0000 | USD | 1 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
0001654954-25-005754 | 20250331 | Share Based Compensation | 0.0000 | USD | 1 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
0001654954-25-005754 | 20231231 | Stockholders Equity | 0.0000 | USD | 0 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
0001654954-25-005754 | 20250331 | Stockholders Equity | 27731753.0000 | USD | 0 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
0001654954-25-005754 | 20231231 | Accounts Receivable Net | 1648904.0000 | USD | 0 | us-gaap/2024 | Related Party Transactions By Related Party= One Year Support Contracts; | ||
0001654954-25-005754 | 20250331 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect | -2595243.0000 | USD | 1 | us-gaap/2024 | |||
0001654954-25-005754 | 20250331 | Common Stock Shares Outstanding | 31844471.0000 | shares | 0 | us-gaap/2024 | |||
0001654954-25-005754 | 20241231 | Common Stock Value | 3056.0000 | USD | 0 | us-gaap/2024 | |||
0001654954-25-005754 | 20250331 | Comprehensive Income Net Of Tax | 23700576.0000 | USD | 1 | us-gaap/2024 | |||
0001654954-25-005754 | 20241231 | Deferred Revenue Current | 3238483.0000 | USD | 0 | us-gaap/2024 | Related Party Transactions By Related Party= One Year Support Contracts; | ||
0001654954-25-005754 | 20250331 | Deferred Revenue Current | 2948695.0000 | USD | 0 | us-gaap/2024 | Related Party Transactions By Related Party= One Year Support Contracts; | ||
0001654954-25-005754 | 20250331 | Earnings Per Share Basic | 0.7500 | USD | 1 | us-gaap/2024 | |||
0001654954-25-005754 | 20250331 | Foreign Currency Transaction Gain Loss Before Tax | -7409.0000 | USD | 1 | us-gaap/2024 | |||
0001654954-25-005754 | 20240331 | Gain Loss On Note Conversion | -158794.0000 | USD | 1 | 0001654954-25-005754 | |||
0001654954-25-005754 | 20240331 | Issuance Of Common Stock For Earnout Shares | 0.0000 | USD | 1 | 0001654954-25-005754 | |||
0001654954-25-005754 | 20250331 | Issuance Of Common Stock For Stock Options Exercise Amount | 8.0000 | USD | 1 | 0001654954-25-005754 | Equity Components= Common Stock Shares; | ||
0001654954-25-005754 | 20250331 | Issuance Of Common Stock For Stock Options Exercise Shares | 81952.0000 | shares | 1 | 0001654954-25-005754 | Equity Components= Common Stock Shares; | ||
0001654954-25-005754 | 20250331 | Liabilities And Stockholders Equity | 12931066.0000 | USD | 0 | us-gaap/2024 | |||
0001654954-25-005754 | 20241231 | Liabilities Current | 5654790.0000 | USD | 0 | us-gaap/2024 | |||
0001654954-25-005754 | 20250331 | Net Cash Provided By Used In Financing Activities | -497399.0000 | USD | 1 | us-gaap/2024 | |||
0001654954-25-005754 | 20250331 | Net Income Loss | 0.0000 | USD | 1 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
0001654954-25-005754 | 20241231 | Operating Lease Liability Noncurrent | 638525.0000 | USD | 0 | us-gaap/2024 | |||
0001654954-25-005754 | 20250331 | Operating Lease Right Of Use Asset | 1102967.0000 | USD | 0 | us-gaap/2024 | |||
0001654954-25-005754 | 20250331 | Other Restructuring Costs | 32916.0000 | USD | 1 | us-gaap/2024 | |||
0001654954-25-005754 | 20240331 | Post Contract Support Cost Of Revenue | 157479.0000 | USD | 1 | 0001654954-25-005754 | |||
0001654954-25-005754 | 20241231 | Preferred Stock Shares Issued | 0.0000 | shares | 0 | us-gaap/2024 | |||
0001654954-25-005754 | 20240331 | Profit Loss | -31964469.0000 | USD | 1 | us-gaap/2024 | |||
0001654954-25-005754 | 20240331 | Revenues | 10575015.0000 | USD | 1 | us-gaap/2024 | |||
0001654954-25-005754 | 20240331 | Share Based Compensation | 135227.0000 | USD | 1 | us-gaap/2024 | Plan Name= Stock Incentive Plan; | ||
0001654954-25-005754 | 20231231 | Stockholders Equity | -17476700.0000 | USD | 0 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
0001654954-25-005754 | 20241231 | Stockholders Equity | 21918867.0000 | USD | 0 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
0001654954-25-005754 | 20240331 | Stock Issued During Period Shares Issued For Services | 15000.0000 | shares | 1 | us-gaap/2024 | Equity Components= Common Stock Shares; | ||
0001654954-25-005754 | 20240331 | Stock Issued During Period Value Conversion Of Units | 835610.0000 | USD | 1 | us-gaap/2024 | |||
0001654954-25-005754 | 20240331 | Stock Issued During Period Value Conversion Of Units | 0.0000 | USD | 1 | us-gaap/2024 | Equity Components= Accumulated Other Comprehensive Income; | ||
0001654954-25-005754 | 20240331 | Weighted Average Number Of Shares Issued Basic | 22898487.0000 | shares | 1 | us-gaap/2024 | |||
0001654954-25-005754 | 20250331 | Common Stock Value | 3182.0000 | USD | 0 | us-gaap/2024 | |||
0001654954-25-005754 | 20250331 | Deferred Revenue Noncurrent | 2528716.0000 | USD | 0 | us-gaap/2024 | |||
0001654954-25-005754 | 20241231 | Accounts Payable Current | 759480.0000 | USD | 0 | us-gaap/2024 | |||
0001654954-25-005754 | 20250331 | Accounts Payable Current | 2179847.0000 | USD | 0 | us-gaap/2024 | |||
0001654954-25-005754 | 20241231 | Accounts Receivable Net | 1226757.0000 | USD | 0 | us-gaap/2024 | Related Party Transactions By Related Party= One Year Support Contracts; | ||
0001654954-25-005754 | 20250331 | Accounts Receivable Net | 2782650.0000 | USD | 0 | us-gaap/2024 | Related Party Transactions By Related Party= One Year Support Contracts; | ||
0001654954-25-005754 | 20241231 | Accrued Liabilities Current | 51649.0000 | USD | 0 | us-gaap/2024 | |||
0001654954-25-005754 | 20241231 | Accumulated Other Comprehensive Income Loss Net Of Tax | -3470.0000 | USD | 0 | us-gaap/2024 | |||
0001654954-25-005754 | 20250331 | Assets | 12931066.0000 | USD | 0 | us-gaap/2024 | |||
0001654954-25-005754 | 20240331 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | 1725817.0000 | USD | 0 | us-gaap/2024 | |||
0001654954-25-005754 | 20241231 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | 11414830.0000 | USD | 0 | us-gaap/2024 | |||
0001654954-25-005754 | 20250331 | Common Stock Shares Issued | 31844471.0000 | shares | 0 | us-gaap/2024 | |||
0001654954-25-005754 | 20241231 | Common Stock Shares Outstanding | 30588413.0000 | shares | 0 | us-gaap/2024 | |||
0001654954-25-005754 | 20240229 | Common Stock Value | 835610.0000 | USD | 0 | us-gaap/2024 | Debt Instrument= Platinum Capital Partner Inc; | ||
0001654954-25-005754 | 20241231 | Earnout Liability | 7825000.0000 | USD | 0 | 0001654954-25-005754 | Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level1; | ||
0001654954-25-005754 | 20250331 | Earnout Liability | 7855178.0000 | USD | 0 | 0001654954-25-005754 | Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level3; | ||
0001654954-25-005754 | 20240331 | Gain Loss From Change In Fair Value Of Earnout Liability | -21484850.0000 | USD | 1 | 0001654954-25-005754 | |||
0001654954-25-005754 | 20240331 | Gain Loss From Change In Fair Value Of Warrant Liability | -6847091.0000 | USD | 1 | 0001654954-25-005754 | |||
0001654954-25-005754 | 20250331 | Gain Loss From Change In Fair Value Of Warrant Liability | 15521183.0000 | USD | 1 | 0001654954-25-005754 | |||
0001654954-25-005754 | 20241231 | Guaranty Liabilities | 34180618.0000 | USD | 0 | us-gaap/2024 | |||
0001654954-25-005754 | 20240331 | Income Taxes Paid Net | 2410.0000 | USD | 1 | us-gaap/2024 | |||
0001654954-25-005754 | 20250331 | Income Taxes Paid Net | 0.0000 | USD | 1 | us-gaap/2024 | |||
0001654954-25-005754 | 20240331 | Increase Decrease In Accounts Payable Trade | 433415.0000 | USD | 1 | us-gaap/2024 | |||
0001654954-25-005754 | 20250331 | Increase Decrease In Accounts Payable Trade | 1429270.0000 | USD | 1 | us-gaap/2024 | |||
0001654954-25-005754 | 20250331 | Increase Decrease In Deferred Revenue | -712922.0000 | USD | 1 | us-gaap/2024 | |||
0001654954-25-005754 | 20240331 | Increase Decrease In Operating Lease Liability | -67211.0000 | USD | 1 | us-gaap/2024 | |||
0001654954-25-005754 | 20250331 | Issuance Of Common Stock For Debt Conversion | 0.0000 | USD | 1 | 0001654954-25-005754 | |||
0001654954-25-005754 | 20250331 | Issuance Of Common Stock For Earnout Shares Amount | 117.0000 | USD | 1 | 0001654954-25-005754 | Equity Components= Common Stock Shares; | ||
0001654954-25-005754 | 20240331 | Issuance Of Common Stock For Exercise Of Warrants Shares | 162867.0000 | shares | 1 | 0001654954-25-005754 | Equity Components= Common Stock Shares; | ||
0001654954-25-005754 | 20240331 | Issuance Of Common Stock For Exercise Of Warrants Value | 293249.0000 | USD | 1 | 0001654954-25-005754 | |||
0001654954-25-005754 | 20250331 | Issuance Of Common Stock For Exercise Of Warrants Value | 1.0000 | USD | 1 | 0001654954-25-005754 | Equity Components= Common Stock Shares; | ||
0001654954-25-005754 | 20250331 | Net Cash Provided By Used In Operating Activities | -2097844.0000 | USD | 1 | us-gaap/2024 | |||
0001654954-25-005754 | 20240331 | Net Income Loss | 0.0000 | USD | 1 | us-gaap/2024 | Equity Components= Common Stock Shares; | ||
0001654954-25-005754 | 20250331 | Net Income Loss | 0.0000 | USD | 1 | us-gaap/2024 | Equity Components= Common Stock Shares; | ||
0001654954-25-005754 | 20250331 | Operating Lease Liability Current | 405916.0000 | USD | 0 | us-gaap/2024 | |||
0001654954-25-005754 | 20250331 | Operating Lease Liability Noncurrent | 758376.0000 | USD | 0 | us-gaap/2024 | |||
0001654954-25-005754 | 20240331 | Operating Lease Right Of Use Asset Amortization Expense | 80291.0000 | USD | 1 | us-gaap/2024 | |||
0001654954-25-005754 | 20250331 | Operating Lease Right Of Use Asset Amortization Expense | 83396.0000 | USD | 1 | us-gaap/2024 | |||
0001654954-25-005754 | 20250331 | Preferred Stock Shares Issued | 0.0000 | shares | 0 | us-gaap/2024 | |||
0001654954-25-005754 | 20240331 | Proceed From Convertible Debt | -2039377.0000 | USD | 1 | 0001654954-25-005754 | |||
0001654954-25-005754 | 20250331 | Proceeds From Stock Options Exercised | 43201.0000 | USD | 1 | us-gaap/2024 | |||
0001654954-25-005754 | 20250331 | Retained Earnings Accumulated Deficit | -51233605.0000 | USD | 0 | us-gaap/2024 | |||
0001654954-25-005754 | 20231231 | Stockholders Equity | -17487227.0000 | USD | 0 | us-gaap/2024 | |||
0001654954-25-005754 | 20231231 | Stockholders Equity | -12808.0000 | USD | 0 | us-gaap/2024 | Equity Components= Accumulated Other Comprehensive Income; | ||
0001654954-25-005754 | 20241231 | Stockholders Equity | -53023137.0000 | USD | 0 | us-gaap/2024 | |||
0001654954-25-005754 | 20241231 | Accounts Receivable Net | 1226757.0000 | USD | 0 | us-gaap/2024 | |||
0001654954-25-005754 | 20250331 | Accumulated Other Comprehensive Income Loss Net Of Tax | -10879.0000 | USD | 0 | us-gaap/2024 | |||
0001654954-25-005754 | 20241231 | Cash And Cash Equivalents At Carrying Value | 11414830.0000 | USD | 0 | us-gaap/2024 | |||
0001654954-25-005754 | 20240630 | Common Stock Shares Issued | 232360.0000 | shares | 0 | us-gaap/2024 | Class Of Stock= Platinum Shares Common Stock; | ||
0001654954-25-005754 | 20241231 | Common Stock Shares Issued | 30588413.0000 | shares | 0 | us-gaap/2024 | |||
0001654954-25-005754 | 20240331 | Cost Of Goods And Services Sold | 7789409.0000 | USD | 1 | us-gaap/2024 | |||
0001654954-25-005754 | 20241231 | Deferred Revenue Current | 3238483.0000 | USD | 0 | us-gaap/2024 | Deferred Revenue Arrangement Type= Revenues; | ||
0001654954-25-005754 | 20241231 | Deferred Revenue Noncurrent | 2951850.0000 | USD | 0 | us-gaap/2024 | |||
0001654954-25-005754 | 20250331 | Earnout Liability | 343901.0000 | USD | 0 | 0001654954-25-005754 | Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level1; | ||
0001654954-25-005754 | 20240331 | Foreign Currency Transaction Gain Loss Before Tax | 3239.0000 | USD | 1 | us-gaap/2024 | |||
0001654954-25-005754 | 20240331 | Foreign Currency Transaction Gain Loss Before Tax | 0.0000 | USD | 1 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
0001654954-25-005754 | 20240331 | Foreign Currency Transaction Gain Loss Before Tax | 0.0000 | USD | 1 | us-gaap/2024 | Equity Components= Common Stock Shares; | ||
0001654954-25-005754 | 20250331 | Gain Loss On Note Conversion | 0.0000 | USD | 1 | 0001654954-25-005754 | |||
0001654954-25-005754 | 20250331 | Increase Decrease In Accounts Receivable | 1555893.0000 | USD | 1 | us-gaap/2024 | |||
0001654954-25-005754 | 20250331 | Interest Paid Net | 0.0000 | USD | 1 | us-gaap/2024 | |||
0001654954-25-005754 | 20250331 | Issuance Of Common Stock For Earnout Shares Amount | 0.0000 | USD | 1 | 0001654954-25-005754 | Equity Components= Accumulated Other Comprehensive Income; | ||
0001654954-25-005754 | 20240331 | Issuance Of Common Stock For Exercise Of Warrants Value | 293233.0000 | USD | 1 | 0001654954-25-005754 | Equity Components= Additional Paid In Capital; | ||
0001654954-25-005754 | 20240331 | Issuance Of Common Stock For Exercise Of Warrants Value | 0.0000 | USD | 1 | 0001654954-25-005754 | Equity Components= Retained Earnings; | ||
0001654954-25-005754 | 20250331 | Issuance Of Common Stock For Exercise Of Warrants Value | 0.0000 | USD | 1 | 0001654954-25-005754 | Equity Components= Accumulated Other Comprehensive Income; | ||
0001654954-25-005754 | 20240331 | Net Cash Provided By Used In Operating Activities | -1695084.0000 | USD | 1 | us-gaap/2024 | |||
0001654954-25-005754 | 20240331 | Net Income Loss | 0.0000 | USD | 1 | us-gaap/2024 | Equity Components= Accumulated Other Comprehensive Income; | ||
0001654954-25-005754 | 20240331 | Post Contract Support Revenue | 1176239.0000 | USD | 1 | 0001654954-25-005754 | |||
0001654954-25-005754 | 20250331 | Preferred Stock No Par Value | 0.0000 | USD | 0 | us-gaap/2024 | |||
0001654954-25-005754 | 20241231 | Preferred Stock Shares Authorized | 5000000.0000 | shares | 0 | us-gaap/2024 | |||
0001654954-25-005754 | 20241231 | Preferred Stock Shares Outstanding | 0.0000 | shares | 0 | us-gaap/2024 | |||
0001654954-25-005754 | 20250331 | Prepaid Expense And Other Assets Current | 67311.0000 | USD | 0 | us-gaap/2024 | |||
0001654954-25-005754 | 20250331 | Research And Development Expense | 719382.0000 | USD | 1 | us-gaap/2024 | Related Party Transactions By Related Party= One Year Support Contracts; | ||
0001654954-25-005754 | 20240331 | Revenues | 9400000.0000 | USD | 1 | us-gaap/2024 | Timing Of Transfer Of Good Or Service= Transferred At Point In Time; | ||
0001654954-25-005754 | 20240331 | Revenues | 1200000.0000 | USD | 1 | us-gaap/2024 | Timing Of Transfer Of Good Or Service= Transferred Over Time; | ||
0001654954-25-005754 | 20250331 | Selling General And Administrative Expense | 3229979.0000 | USD | 1 | us-gaap/2024 | |||
0001654954-25-005754 | 20240331 | Share Based Compensation | 0.0000 | USD | 1 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
0001654954-25-005754 | 20250331 | Share Based Compensation | 428286.0000 | USD | 1 | us-gaap/2024 | |||
0001654954-25-005754 | 20250331 | Share Based Compensation | 0.0000 | USD | 1 | us-gaap/2024 | Equity Components= Accumulated Other Comprehensive Income; | ||
0001654954-25-005754 | 20250331 | Share Based Compensation | 0.0000 | USD | 1 | us-gaap/2024 | Equity Components= Common Stock Shares; | ||
0001654954-25-005754 | 20250331 | Shares Issued | 879051.0000 | shares | 0 | us-gaap/2024 | Debt Instrument= Platinum Capital Partner Inc; | ||
0001654954-25-005754 | 20240331 | Stockholders Equity | -9569.0000 | USD | 0 | us-gaap/2024 | Equity Components= Accumulated Other Comprehensive Income; | ||
0001654954-25-005754 | 20241231 | Stockholders Equity | 3056.0000 | USD | 0 | us-gaap/2024 | Equity Components= Common Stock Shares; | ||
0001654954-25-005754 | 20240331 | Stock Issued During Period Value Conversion Of Units | 0.0000 | USD | 1 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
0001654954-25-005754 | 20240331 | Stock Issued During Period Value Issued For Services | 0.0000 | USD | 1 | us-gaap/2024 | Equity Components= Accumulated Other Comprehensive Income; |
Field Name | Field Description |
---|---|
adsh | Accession Number. The 20-character string formed from the 18-digit number assigned by the SEC to each EDGAR submission. |
tag | The unique identifier (name) for a tag in a specific taxonomy release. |
version | For a standard tag, an identifier for the taxonomy; otherwise the accession number where the tag was defined. |
ddate | The end date for the data value, rounded to the nearest month end. |
qtrs | The count of the number of quarters represented by the data value, rounded to the nearest whole number. “0” indicates it is a point-in-time value. |
uom | The unit of measure for the value. |
segments | Tags used to represent axis and member reporting. |
coreg | If specified, indicates a specific co-registrant, the parent company, or other entity (e.g., guarantor). NULL indicates the consolidated entity. |
value | The value. This is not scaled, it is as found in the Interactive Data file, but is limited to four digits to the right of the decimal point. |
footnote | The text of any superscripted footnotes on the value, as shown on the statement page, truncated to 512 characters, or if there is no footnote, then this field will be blank. |
tag | version | custom | abstract | datatype | iord | crdr | tlabel | doc |
---|---|---|---|---|---|---|---|---|
Gain Loss On Note Conversions | 0001654954-25-005754 | 1 | 0 | monetary | D | C | [Loss on note conversion] | |
Increase Decrease In Accounts Receivable | us-gaap/2024 | 0 | 0 | monetary | D | C | Increase (Decrease) in Accounts Receivable | The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services. |
Assets Current | us-gaap/2024 | 0 | 0 | monetary | I | D | Assets, Current | Amount of asset recognized for present right to economic benefit, classified as current. |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | us-gaap/2024 | 0 | 0 | monetary | I | D | Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents | Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. |
Increase Decrease In Prepaid Expenses Other | us-gaap/2024 | 0 | 0 | monetary | D | C | Increase (Decrease) in Prepaid Expenses, Other | Amount of increase (decrease) of consideration paid in advance for other costs that provide economic benefits in future periods. |
Operating Lease Liability Current | us-gaap/2024 | 0 | 0 | monetary | I | C | Operating Lease, Liability, Current | Present value of lessee's discounted obligation for lease payments from operating lease, classified as current. |
Stock Issued During Period Value Conversion Of Units | us-gaap/2024 | 0 | 0 | monetary | D | C | Stock Issued During Period, Value, Conversion of Units | Value of stock issued during the period upon the conversion of units. An example of a convertible unit is an umbrella partnership real estate investment trust unit (UPREIT unit). |
Increase Decrease In Accounts Payable Trade | us-gaap/2024 | 0 | 0 | monetary | D | D | Increase (Decrease) in Accounts Payable, Trade | Change in recurring obligations of a business that arise from the acquisition of merchandise, materials, supplies and services used in the production and sale of goods and services. |
Depreciation And Amortization | us-gaap/2024 | 0 | 0 | monetary | D | D | Depreciation, Depletion and Amortization, Nonproduction | The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production. |
Post Contract Support Revenue | 0001654954-25-005754 | 1 | 0 | monetary | D | C | Post contract support | |
Comprehensive Income Net Of Tax | us-gaap/2024 | 0 | 0 | monetary | D | C | Comprehensive Income (Loss), Net of Tax, Attributable to Parent | Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners. |
Deferred Revenue Current | us-gaap/2024 | 0 | 0 | monetary | I | C | Deferred Revenue, Current | Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable, classified as current. |
Liabilities | us-gaap/2024 | 0 | 0 | monetary | I | C | Liabilities | Amount of liability recognized for present obligation requiring transfer or otherwise providing economic benefit to others. |
Liabilities And Stockholders Equity | us-gaap/2024 | 0 | 0 | monetary | I | C | Liabilities and Equity | Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any. |
Proceeds From Stock Options Exercised | us-gaap/2024 | 0 | 0 | monetary | D | D | Proceeds from Stock Options Exercised | Amount of cash inflow from exercise of option under share-based payment arrangement. |
Retained Earnings Accumulated Deficit | us-gaap/2024 | 0 | 0 | monetary | I | C | Retained Earnings (Accumulated Deficit) | Amount of accumulated undistributed earnings (deficit). |
Stock Issued During Period Shares Issued For Services | us-gaap/2024 | 0 | 0 | shares | D | Stock Issued During Period, Shares, Issued for Services | Number of shares issued in lieu of cash for services contributed to the entity. Number of shares includes, but is not limited to, shares issued for services contributed by vendors and founders. | |
Gain Loss From Change In Fair Value Of Warrant Liability | 0001654954-25-005754 | 1 | 0 | monetary | D | C | Gain (loss) from change in fair value of warrant liability | |
Advances From Founder | 0001654954-25-005754 | 1 | 0 | monetary | I | C | Advances from founders | |
Stockholders Equity | us-gaap/2024 | 0 | 0 | monetary | I | C | Equity, Attributable to Parent | Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest. |
Additional Paid In Capital | us-gaap/2024 | 0 | 0 | monetary | I | C | Additional Paid in Capital | Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock. |
Common Stock Par Or Stated Value Per Share | us-gaap/2024 | 0 | 0 | perShare | I | Common Stock, Par or Stated Value Per Share | Face amount or stated value per share of common stock. | |
Common Stock Shares Outstanding | us-gaap/2024 | 0 | 0 | shares | I | Common Stock, Shares, Outstanding | Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation. | |
Income Tax Expense Benefit | us-gaap/2024 | 0 | 0 | monetary | D | D | Income Tax Expense (Benefit) | Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations. |
Net Income Loss | us-gaap/2024 | 0 | 0 | monetary | D | C | Net Income (Loss) Attributable to Parent | The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. |
Weighted Average Number Of Diluted Shares Outstanding | us-gaap/2024 | 0 | 0 | shares | D | Weighted Average Number of Shares Outstanding, Diluted | The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period. | |
Accounts Receivable Net | us-gaap/2024 | 0 | 0 | monetary | I | D | Accounts Receivable, after Allowance for Credit Loss | Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business. |
Gain Loss On Note Conversion | 0001654954-25-005754 | 1 | 0 | monetary | D | C | Loss on note conversion | |
Issuance Of Common Stock For Earnout Shares Shares | 0001654954-25-005754 | 1 | 0 | shares | D | Issuance of common stock for earnout shares, shares | ||
Recognition Of Operating Lease Liability | 0001654954-25-005754 | 1 | 0 | monetary | D | D | Recognition of operating lease liability | |
Accumulated Other Comprehensive Income Loss Net Of Tax | us-gaap/2024 | 0 | 0 | monetary | I | C | Accumulated Other Comprehensive Income (Loss), Net of Tax | Amount, after tax, of accumulated increase (decrease) in equity from transaction and other event and circumstance from nonowner source. |
Allowance For Doubtful Accounts Receivable | us-gaap/2024 | 0 | 0 | monetary | I | C | Accounts Receivable, Allowance for Credit Loss | Amount of allowance for credit loss on accounts receivable. |
Assets | us-gaap/2024 | 0 | 0 | monetary | I | D | Assets | Amount of asset recognized for present right to economic benefit. |
Earnings Per Share Diluted | us-gaap/2024 | 0 | 0 | perShare | D | Earnings Per Share, Diluted | The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period. | |
Common Stock Shares Issued | us-gaap/2024 | 0 | 0 | shares | I | Common Stock, Shares, Issued | Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury. | |
Cost Of Goods And Services Sold | us-gaap/2024 | 0 | 0 | monetary | D | D | Cost of Goods and Services Sold | The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities. |
Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | us-gaap/2024 | 0 | 0 | monetary | D | D | Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Continuing Operations | Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. |
Guaranty Liabilities | us-gaap/2024 | 0 | 0 | monetary | I | C | Guaranty Liabilities | This item represents a non-contingent liability for the fair value of an obligation to stand ready to perform over the term of a guaranty issued in the event that specified triggering events or conditions occur. |
Operating Lease Right Of Use Asset | us-gaap/2024 | 0 | 0 | monetary | I | D | Operating Lease, Right-of-Use Asset | Amount of lessee's right to use underlying asset under operating lease. |
Gross Profit | us-gaap/2024 | 0 | 0 | monetary | D | C | Gross Profit | Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity. |
Cost Of Revenue | us-gaap/2024 | 0 | 0 | monetary | D | D | Cost of Revenue | The aggregate cost of goods produced and sold and services rendered during the reporting period. |
Shares Issued | us-gaap/2024 | 0 | 0 | shares | I | Shares, Issued | Number of shares of stock issued as of the balance sheet date, including shares that had been issued and were previously outstanding but which are now held in the treasury. | |
Weighted Average Number Of Shares Issued Basic | us-gaap/2024 | 0 | 0 | shares | D | Weighted Average Number of Shares Issued, Basic | This element represents the weighted average total number of shares issued throughout the period including the first (beginning balance outstanding) and last (ending balance outstanding) day of the period before considering any reductions (for instance, shares held in treasury) to arrive at the weighted average number of shares outstanding. Weighted average relates to the portion of time within a reporting period that common shares have been issued and outstanding to the total time in that period. Such concept is used in determining the weighted average number of shares outstanding for purposes of calculating earnings per share (basic). | |
Issuance Of Common Stock For Stock Options Exercise Shares | 0001654954-25-005754 | 1 | 0 | shares | D | Issuance of common stock for stock options exercise, shares | ||
Accrued Liabilities Current | us-gaap/2024 | 0 | 0 | monetary | I | C | Accrued Liabilities, Current | Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). |
Increase Decrease In Income Taxes Receivable | us-gaap/2024 | 0 | 0 | monetary | D | C | Increase (Decrease) in Income Taxes Receivable | The increase (decrease) during the reporting period in income taxes receivable, which represents the amount due from tax authorities for refunds of overpayments or recoveries of income taxes paid. |
Increase Decrease In Other Operating Assets | us-gaap/2024 | 0 | 0 | monetary | D | C | Increase (Decrease) in Other Operating Assets | Amount of increase (decrease) in operating assets classified as other. |
Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax | us-gaap/2024 | 0 | 0 | monetary | D | C | Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax | Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature. |
Liabilities Current | us-gaap/2024 | 0 | 0 | monetary | I | C | Liabilities, Current | Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer. |
Other Restructuring Costs | us-gaap/2024 | 0 | 0 | monetary | D | D | Other Restructuring Costs | Amount of other expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses associated with a discontinued operation or an asset retirement obligation. |
Selling General And Administrative Expense | us-gaap/2024 | 0 | 0 | monetary | D | D | Selling, General and Administrative Expense | The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc. |
Share Based Compensation | us-gaap/2024 | 0 | 0 | monetary | D | D | Share-Based Payment Arrangement, Noncash Expense | Amount of noncash expense for share-based payment arrangement. |
Stock Issued During Period Value Issued For Services | us-gaap/2024 | 0 | 0 | monetary | D | C | Stock Issued During Period, Value, Issued for Services | Value of stock issued in lieu of cash for services contributed to the entity. Value of the stock issued includes, but is not limited to, services contributed by vendors and founders. |
Issuance Of Common Stock For Earnout Shares Amount | 0001654954-25-005754 | 1 | 0 | monetary | D | C | Issuance of common stock for earnout shares, amount | |
Preferred Stock Shares Issued | us-gaap/2024 | 0 | 0 | shares | I | Preferred Stock, Shares Issued | Number of shares issued for nonredeemable preferred shares and preferred shares redeemable solely at option of issuer. Includes, but is not limited to, preferred shares issued, repurchased, and held as treasury shares. Excludes preferred shares classified as debt. | |
Proceed From Convertible Debt | 0001654954-25-005754 | 1 | 0 | monetary | D | C | Loss from change in fair value of convertible debt | |
Issuance Of Common Stock For Exercise Of Warrants Shares | 0001654954-25-005754 | 1 | 0 | shares | D | Issuance of common stock for exercise of warrants, shares | ||
Cash And Cash Equivalents At Carrying Value | us-gaap/2024 | 0 | 0 | monetary | I | D | Cash and Cash Equivalents, at Carrying Value | Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation. |
Deferred Revenue Noncurrent | us-gaap/2024 | 0 | 0 | monetary | I | C | Deferred Revenue, Noncurrent | Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable, classified as noncurrent. |
Foreign Currency Transaction Gain Loss Before Tax | us-gaap/2024 | 0 | 0 | monetary | D | C | Gain (Loss), Foreign Currency Transaction, before Tax | Amount, before tax, of realized and unrealized gain (loss) from foreign currency transaction. |
Income Taxes Paid Net | us-gaap/2024 | 0 | 0 | monetary | D | C | Income Taxes Paid, Net | Amount, after refund, of cash paid to foreign, federal, state, and local jurisdictions as income tax. |
Preferred Stock Value | us-gaap/2024 | 0 | 0 | monetary | I | C | Preferred Stock, Value, Issued | Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity. |
Profit Loss | us-gaap/2024 | 0 | 0 | monetary | D | C | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest | The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest. |
Repayments Of Related Party Debt | us-gaap/2024 | 0 | 0 | monetary | D | C | Repayments of Related Party Debt | The cash outflow for the payment of a long-term borrowing made from a related party where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth. Alternate caption: Payments for Advances from Affiliates. |
Interest Income Expense Net | us-gaap/2024 | 0 | 0 | monetary | D | C | Interest Income (Expense), Operating | Amount of interest income (expense) classified as operating. |
Net Cash Provided By Used In Operating Activities | us-gaap/2024 | 0 | 0 | monetary | D | Net Cash Provided by (Used in) Operating Activities | Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities. | |
Operating Expenses | us-gaap/2024 | 0 | 0 | monetary | D | D | Operating Expenses | Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense. |
Operating Income Loss | us-gaap/2024 | 0 | 0 | monetary | D | C | Operating Income (Loss) | The net result for the period of deducting operating expenses from operating revenues. |
Prepaid Expense And Other Assets Current | us-gaap/2024 | 0 | 0 | monetary | I | D | Prepaid Expense and Other Assets, Current | Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer. |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect | us-gaap/2024 | 0 | 0 | monetary | D | D | Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect | Amount of increase (decrease) in cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; excluding effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. |
Issuance Of Common Stock For Debt Conversion | 0001654954-25-005754 | 1 | 0 | monetary | D | D | Issuance of common stock for debt conversion | |
Post Contract Support Cost Of Revenue | 0001654954-25-005754 | 1 | 0 | monetary | D | D | [Post contract support] | |
Common Stock Value | us-gaap/2024 | 0 | 0 | monetary | I | C | Common Stock, Value, Issued | Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity. |
Gain Loss From Change In Fair Value Of Convertible Note | 0001654954-25-005754 | 1 | 0 | monetary | D | C | [Loss from change in fair value of convertible note] | |
Research And Development Expense | us-gaap/2024 | 0 | 0 | monetary | D | D | Research and Development Expense | Amount of expense for research and development. Includes, but is not limited to, cost for computer software product to be sold, leased, or otherwise marketed and writeoff of research and development assets acquired in transaction other than business combination or joint venture formation or both. Excludes write-down of intangible asset acquired in business combination or from joint venture formation or both, used in research and development activity. |
Revenues | us-gaap/2024 | 0 | 0 | monetary | D | C | Revenues | Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss). |
Gain Loss From Change In Fair Value Of Earnout Liability | 0001654954-25-005754 | 1 | 0 | monetary | D | C | Gain (loss) from change in fair value of earnout liability | |
Other Services Revenue | 0001654954-25-005754 | 1 | 0 | shares | D | Other services | ||
Accounts Payable Current | us-gaap/2024 | 0 | 0 | monetary | I | C | Accounts Payable, Current | Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). |
Common Stock Shares Authorized | us-gaap/2024 | 0 | 0 | shares | I | Common Stock, Shares Authorized | The maximum number of common shares permitted to be issued by an entity's charter and bylaws. | |
Income Loss From Subsidiaries Before Tax | us-gaap/2024 | 0 | 0 | monetary | D | C | Income (Loss) from Subsidiaries, before Tax | Amount before tax of income (loss) of subsidiary attributable to the parent entity. |
Increase Decrease In Operating Lease Liability | us-gaap/2024 | 0 | 0 | monetary | D | D | Increase (Decrease) in Operating Lease Liability | Amount of increase (decrease) in obligation for operating lease. |
Interest Paid Net | us-gaap/2024 | 0 | 0 | monetary | D | C | Interest Paid, Excluding Capitalized Interest, Operating Activities | Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount. |
Net Cash Provided By Used In Financing Activities | us-gaap/2024 | 0 | 0 | monetary | D | D | Net Cash Provided by (Used in) Financing Activities | Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit. |
Operating Lease Right Of Use Asset Amortization Expense | us-gaap/2024 | 0 | 0 | monetary | D | D | Operating Lease, Right-of-Use Asset, Periodic Reduction | Amount of periodic reduction over lease term of carrying amount of right-of-use asset from operating lease. |
Stock Issued During Period Shares Conversion Of Units | us-gaap/2024 | 0 | 0 | shares | D | Stock Issued During Period, Shares, Conversion of Units | The number of shares issued during the period upon the conversion of units. An example of a convertible unit is an umbrella partnership real estate investment trust unit (UPREIT unit). | |
Earnout Liability | 0001654954-25-005754 | 1 | 0 | monetary | I | C | Earnout liability | |
Earnings Per Share Basic | us-gaap/2024 | 0 | 0 | perShare | D | Earnings Per Share, Basic | The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period. | |
Other Nonoperating Income Expense | us-gaap/2024 | 0 | 0 | monetary | D | C | Other Nonoperating Income (Expense) | Amount of income (expense) related to nonoperating activities, classified as other. |
Preferred Stock No Par Value | us-gaap/2024 | 0 | 0 | perShare | I | Preferred Stock, No Par Value | Face amount per share of no-par value preferred stock nonredeemable or redeemable solely at the option of the issuer. | |
Preferred Stock Shares Authorized | us-gaap/2024 | 0 | 0 | shares | I | Preferred Stock, Shares Authorized | The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws. | |
Preferred Stock Shares Outstanding | us-gaap/2024 | 0 | 0 | shares | I | Preferred Stock, Shares Outstanding | Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased. | |
Proceeds From Warrant Exercises | us-gaap/2024 | 0 | 0 | monetary | D | D | Proceeds from Warrant Exercises | The cash inflow associated with the amount received from holders exercising their stock warrants. |
Issuance Of Common Stock For Exercise Of Warrants Value | 0001654954-25-005754 | 1 | 0 | monetary | D | C | Issuance of common stock for exercise of warrants, amount | |
Recognition Of Right Of Use Asset | 0001654954-25-005754 | 1 | 0 | monetary | D | D | Recognition of operating right-of-use asset | |
Increase Decrease In Deferred Revenue | us-gaap/2024 | 0 | 0 | monetary | D | D | Increase (Decrease) in Deferred Revenue | Amount of increase (decrease) in deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable. |
Operating Lease Liability Noncurrent | us-gaap/2024 | 0 | 0 | monetary | I | C | Operating Lease, Liability, Noncurrent | Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent. |
Other Assets | us-gaap/2024 | 0 | 0 | monetary | I | D | Other Assets | Amount of assets classified as other. |
Issuance Of Common Stock For Earnout Shares | 0001654954-25-005754 | 1 | 0 | monetary | D | D | Issuance of common stock for earnout shares | |
Issuance Of Common Stock For Stock Options Exercise Amount | 0001654954-25-005754 | 1 | 0 | monetary | D | C | Issuance of common stock for stock options exercise, amount | |
Product Revenue | 0001654954-25-005754 | 1 | 0 | monetary | D | C | Product |
Field Name | Field Description |
---|---|
tag | The unique identifier (name) for a tag in a specific taxonomy release. |
version | For a standard tag, an identifier for the taxonomy; otherwise the accession number where the tag was defined. |
custom | 1 if tag is custom (version=adsh), 0 if it is standard. Note: This flag is technically redundant with the version and adsh columns. |
abstract | 1 if the tag is not used to represent a numeric fact. |
datatype | If abstract=1, then NULL, otherwise the data type (e.g., monetary) for the tag. |
iord | If abstract=1, then NULL; otherwise, “I” if the value is a point-in time, or “D” if the value is a duration. |
crdr | If datatype = monetary, then the tag’s natural accounting balance (debit or credit); if not defined, then NULL. |
tlabel | If a standard tag, then the label text provided by the taxonomy, otherwise the text provided by the filer. A tag which had neither would have a NULL value here. |
doc | The detailed definition for the tag. If a standard tag, then the text provided by the taxonomy, otherwise the text assigned by the filer. Some tags have neither, and this field is NULL. |
adsh | report | line | stmt | inpth | rfile | tag | version | plabel | negating |
---|---|---|---|---|---|---|---|---|---|
0001654954-25-005754 | 2 | 2 | BS | 0 | H | Cash And Cash Equivalents At Carrying Value | us-gaap/2024 | Cash and cash equivalents | 0 |
0001654954-25-005754 | 2 | 3 | BS | 0 | H | Accounts Receivable Net | us-gaap/2024 | Accounts receivable, net of allowance for credit losses of $0 | 0 |
0001654954-25-005754 | 2 | 4 | BS | 0 | H | Prepaid Expense And Other Assets Current | us-gaap/2024 | Prepaid expenses and other | 0 |
0001654954-25-005754 | 2 | 5 | BS | 0 | H | Assets Current | us-gaap/2024 | Total current assets | 0 |
0001654954-25-005754 | 2 | 6 | BS | 0 | H | Other Assets | us-gaap/2024 | Other assets | 0 |
0001654954-25-005754 | 2 | 7 | BS | 0 | H | Operating Lease Right Of Use Asset | us-gaap/2024 | Operating lease right of use asset | 0 |
0001654954-25-005754 | 2 | 8 | BS | 0 | H | Assets | us-gaap/2024 | TOTAL ASSETS | 0 |
0001654954-25-005754 | 2 | 10 | BS | 0 | H | Accounts Payable Current | us-gaap/2024 | Accounts payable - trade | 0 |
0001654954-25-005754 | 2 | 11 | BS | 0 | H | Advances From Founder | 0001654954-25-005754 | Advances from founders | 0 |
0001654954-25-005754 | 2 | 12 | BS | 0 | H | Accrued Liabilities Current | us-gaap/2024 | Accrued expenses | 0 |
0001654954-25-005754 | 2 | 13 | BS | 0 | H | Operating Lease Liability Current | us-gaap/2024 | Current portion of operating lease liability | 0 |
0001654954-25-005754 | 2 | 14 | BS | 0 | H | Deferred Revenue Current | us-gaap/2024 | Deferred revenue- current portion | 0 |
0001654954-25-005754 | 2 | 15 | BS | 0 | H | Liabilities Current | us-gaap/2024 | Total current liabilities | 0 |
0001654954-25-005754 | 2 | 17 | BS | 0 | H | Operating Lease Liability Noncurrent | us-gaap/2024 | Operating lease liability, net of current portion | 0 |
0001654954-25-005754 | 2 | 18 | BS | 0 | H | Guaranty Liabilities | us-gaap/2024 | Warrant liability | 0 |
0001654954-25-005754 | 2 | 19 | BS | 0 | H | Earnout Liability | 0001654954-25-005754 | Earnout liability | 0 |
0001654954-25-005754 | 2 | 20 | BS | 0 | H | Deferred Revenue Noncurrent | us-gaap/2024 | Deferred revenue- non-current | 0 |
0001654954-25-005754 | 2 | 21 | BS | 0 | H | Liabilities | us-gaap/2024 | Total liabilities | 0 |
0001654954-25-005754 | 2 | 24 | BS | 0 | H | Preferred Stock Value | us-gaap/2024 | Preferred stock - no par value, 5,000,000 shares authorized, 0 shares issued and outstanding as of March 31, 2025 and December 31, 2024 | 0 |
0001654954-25-005754 | 2 | 25 | BS | 0 | H | Common Stock Value | us-gaap/2024 | Common stock - $0.0001 par value, 200,000,000 shares authorized, 31,844,471 and 30,588,413 shares issued and outstanding as of March 31, 2025 and December 31, 2024 | 0 |
0001654954-25-005754 | 2 | 26 | BS | 0 | H | Additional Paid In Capital | us-gaap/2024 | Additional paid in capital | 0 |
0001654954-25-005754 | 2 | 27 | BS | 0 | H | Retained Earnings Accumulated Deficit | us-gaap/2024 | Accumulated deficit | 0 |
0001654954-25-005754 | 2 | 28 | BS | 0 | H | Accumulated Other Comprehensive Income Loss Net Of Tax | us-gaap/2024 | Accumulated other comprehensive loss | 0 |
0001654954-25-005754 | 2 | 29 | BS | 0 | H | Stockholders Equity | us-gaap/2024 | Total stockholders' deficit | 0 |
0001654954-25-005754 | 2 | 30 | BS | 0 | H | Liabilities And Stockholders Equity | us-gaap/2024 | TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT | 0 |
0001654954-25-005754 | 3 | 1 | BS | 1 | H | Allowance For Doubtful Accounts Receivable | us-gaap/2024 | Accounts receivable, net of provision | 0 |
0001654954-25-005754 | 3 | 2 | BS | 1 | H | Preferred Stock No Par Value | us-gaap/2024 | Preferred stock, par value | 0 |
0001654954-25-005754 | 3 | 3 | BS | 1 | H | Preferred Stock Shares Authorized | us-gaap/2024 | Preferred stock, shares authorized | 0 |
0001654954-25-005754 | 3 | 4 | BS | 1 | H | Preferred Stock Shares Issued | us-gaap/2024 | Preferred stock, shares issued | 0 |
0001654954-25-005754 | 3 | 5 | BS | 1 | H | Preferred Stock Shares Outstanding | us-gaap/2024 | Preferred stock, shares outstanding | 0 |
0001654954-25-005754 | 3 | 6 | BS | 1 | H | Common Stock Par Or Stated Value Per Share | us-gaap/2024 | Common stock, par value | 0 |
0001654954-25-005754 | 3 | 7 | BS | 1 | H | Common Stock Shares Authorized | us-gaap/2024 | Common stock, authorized | 0 |
0001654954-25-005754 | 3 | 8 | BS | 1 | H | Common Stock Shares Issued | us-gaap/2024 | Common stock, issued | 0 |
0001654954-25-005754 | 3 | 9 | BS | 1 | H | Common Stock Shares Outstanding | us-gaap/2024 | Common stock, outstanding | 0 |
0001654954-25-005754 | 4 | 1 | IS | 0 | H | Product Revenue | 0001654954-25-005754 | Product | 0 |
0001654954-25-005754 | 4 | 2 | IS | 0 | H | Post Contract Support Revenue | 0001654954-25-005754 | Post contract support | 0 |
0001654954-25-005754 | 4 | 3 | IS | 0 | H | Other Services Revenue | 0001654954-25-005754 | Other services | 0 |
0001654954-25-005754 | 4 | 4 | IS | 0 | H | Revenues | us-gaap/2024 | Revenues | 0 |
0001654954-25-005754 | 4 | 6 | IS | 0 | H | Cost Of Goods And Services Sold | us-gaap/2024 | Cost of Sales | 0 |
0001654954-25-005754 | 4 | 7 | IS | 0 | H | Post Contract Support Cost Of Revenue | 0001654954-25-005754 | Post contract support | 0 |
0001654954-25-005754 | 4 | 8 | IS | 0 | H | Other Restructuring Costs | us-gaap/2024 | Other services | 0 |
0001654954-25-005754 | 4 | 9 | IS | 0 | H | Cost Of Revenue | us-gaap/2024 | Cost of Revenue | 0 |
0001654954-25-005754 | 4 | 10 | IS | 0 | H | Gross Profit | us-gaap/2024 | GROSS PROFIT | 0 |
0001654954-25-005754 | 4 | 11 | IS | 0 | H | Research And Development Expense | us-gaap/2024 | RESEARCH AND DEVELOPMENT EXPENSES | 0 |
0001654954-25-005754 | 4 | 12 | IS | 0 | H | Selling General And Administrative Expense | us-gaap/2024 | SELLING, GENERAL AND ADMINISTRATIVE EXPENSES | 0 |
0001654954-25-005754 | 4 | 13 | IS | 0 | H | Operating Expenses | us-gaap/2024 | TOTAL OPERATING EXPENSES | 0 |
0001654954-25-005754 | 4 | 14 | IS | 0 | H | Operating Income Loss | us-gaap/2024 | OPERATING LOSS | 0 |
0001654954-25-005754 | 4 | 15 | IS | 0 | H | Gain Loss From Change In Fair Value Of Earnout Liability | 0001654954-25-005754 | Gain (loss) from change in fair value of earnout liability | 0 |
0001654954-25-005754 | 4 | 16 | IS | 0 | H | Gain Loss From Change In Fair Value Of Warrant Liability | 0001654954-25-005754 | Gain (loss) from change in fair value of warrant liability | 0 |
0001654954-25-005754 | 4 | 17 | IS | 0 | H | Proceed From Convertible Debt | 0001654954-25-005754 | Loss from change in fair value of convertible debt | 0 |
0001654954-25-005754 | 4 | 18 | IS | 0 | H | Gain Loss On Note Conversion | 0001654954-25-005754 | Loss on note conversion | 0 |
0001654954-25-005754 | 4 | 19 | IS | 0 | H | Interest Income Expense Net | us-gaap/2024 | Interest Income (Expense), Operating | 0 |
0001654954-25-005754 | 4 | 20 | IS | 0 | H | Other Nonoperating Income Expense | us-gaap/2024 | Total other income (expense), net | 0 |
0001654954-25-005754 | 4 | 21 | IS | 0 | H | Income Loss From Subsidiaries Before Tax | us-gaap/2024 | INCOME (LOSS) BEFORE PROVISON FOR INCOME TAXES | 0 |
0001654954-25-005754 | 4 | 22 | IS | 0 | H | Income Tax Expense Benefit | us-gaap/2024 | Provision for income taxes | 0 |
0001654954-25-005754 | 4 | 23 | IS | 0 | H | Net Income Loss | us-gaap/2024 | NET INCOME (LOSS) | 0 |
0001654954-25-005754 | 4 | 24 | IS | 0 | H | Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax | us-gaap/2024 | Foreign currency translation (loss) income, net | 0 |
0001654954-25-005754 | 4 | 25 | IS | 0 | H | Comprehensive Income Net Of Tax | us-gaap/2024 | TOTAL COMPREHENSIVE INCOME (LOSS) | 0 |
0001654954-25-005754 | 4 | 27 | IS | 0 | H | Earnings Per Share Basic | us-gaap/2024 | Basic | 0 |
0001654954-25-005754 | 4 | 28 | IS | 0 | H | Earnings Per Share Diluted | us-gaap/2024 | Diluted | 0 |
0001654954-25-005754 | 4 | 29 | IS | 0 | H | Weighted Average Number Of Shares Issued Basic | us-gaap/2024 | Basic | 0 |
0001654954-25-005754 | 4 | 30 | IS | 0 | H | Weighted Average Number Of Diluted Shares Outstanding | us-gaap/2024 | Diluted | 0 |
0001654954-25-005754 | 5 | 9 | EQ | 0 | H | Stockholders Equity | us-gaap/2024 | Balance, amount | 0 |
0001654954-25-005754 | 5 | 10 | EQ | 0 | H | Shares Issued | us-gaap/2024 | Balance, shares | 0 |
0001654954-25-005754 | 5 | 11 | EQ | 0 | H | Share Based Compensation | us-gaap/2024 | Stock-based compensation | 0 |
0001654954-25-005754 | 5 | 12 | EQ | 0 | H | Stock Issued During Period Shares Issued For Services | us-gaap/2024 | Issuance of common stock for prior period services, shares | 0 |
0001654954-25-005754 | 5 | 13 | EQ | 0 | H | Stock Issued During Period Value Issued For Services | us-gaap/2024 | Issuance of common stock for prior period services, amount | 0 |
0001654954-25-005754 | 5 | 14 | EQ | 0 | H | Stock Issued During Period Value Conversion Of Units | us-gaap/2024 | Issuance of common stock for conversion of debt, amount | 0 |
0001654954-25-005754 | 5 | 15 | EQ | 0 | H | Stock Issued During Period Shares Conversion Of Units | us-gaap/2024 | Issuance of common stock for conversion of debt, shares | 0 |
0001654954-25-005754 | 5 | 16 | EQ | 0 | H | Issuance Of Common Stock For Exercise Of Warrants Value | 0001654954-25-005754 | Issuance of common stock for exercise of warrants, amount | 0 |
0001654954-25-005754 | 5 | 17 | EQ | 0 | H | Issuance Of Common Stock For Exercise Of Warrants Shares | 0001654954-25-005754 | Issuance of common stock for exercise of warrants, shares | 0 |
0001654954-25-005754 | 5 | 18 | EQ | 0 | H | Foreign Currency Transaction Gain Loss Before Tax | us-gaap/2024 | Foreign currency translation gain | 0 |
0001654954-25-005754 | 5 | 19 | EQ | 0 | H | Net Income Loss | us-gaap/2024 | Net loss | 0 |
0001654954-25-005754 | 5 | 20 | EQ | 0 | H | Issuance Of Common Stock For Stock Options Exercise Shares | 0001654954-25-005754 | Issuance of common stock for stock options exercise, shares | 0 |
0001654954-25-005754 | 5 | 21 | EQ | 0 | H | Issuance Of Common Stock For Stock Options Exercise Amount | 0001654954-25-005754 | Issuance of common stock for stock options exercise, amount | 0 |
0001654954-25-005754 | 5 | 22 | EQ | 0 | H | Issuance Of Common Stock For Earnout Shares Shares | 0001654954-25-005754 | Issuance of common stock for earnout shares, shares | 0 |
0001654954-25-005754 | 5 | 23 | EQ | 0 | H | Issuance Of Common Stock For Earnout Shares Amount | 0001654954-25-005754 | Issuance of common stock for earnout shares, amount | 0 |
0001654954-25-005754 | 5 | 24 | EQ | 0 | H | Stockholders Equity | us-gaap/2024 | Balance, amount | 0 |
0001654954-25-005754 | 5 | 25 | EQ | 0 | H | Shares Issued | us-gaap/2024 | Balance, shares | 0 |
0001654954-25-005754 | 6 | 2 | CF | 0 | H | Profit Loss | us-gaap/2024 | Net income (loss) | 0 |
0001654954-25-005754 | 6 | 4 | CF | 0 | H | Depreciation And Amortization | us-gaap/2024 | Depreciation and amortization | 0 |
0001654954-25-005754 | 6 | 5 | CF | 0 | H | Share Based Compensation | us-gaap/2024 | Stock-based compensation | 0 |
0001654954-25-005754 | 6 | 6 | CF | 0 | H | Operating Lease Right Of Use Asset Amortization Expense | us-gaap/2024 | Amortization of operating lease right of use asset | 0 |
0001654954-25-005754 | 6 | 7 | CF | 0 | H | Gain Loss From Change In Fair Value Of Warrant Liability | 0001654954-25-005754 | (Gain) loss from change in fair value of warrant liability | 1 |
0001654954-25-005754 | 6 | 8 | CF | 0 | H | Gain Loss From Change In Fair Value Of Earnout Liability | 0001654954-25-005754 | (Gain) loss from change in fair value of earnout liability | 1 |
0001654954-25-005754 | 6 | 9 | CF | 0 | H | Gain Loss From Change In Fair Value Of Convertible Note | 0001654954-25-005754 | Loss from change in fair value of convertible note | 1 |
0001654954-25-005754 | 6 | 10 | CF | 0 | H | Gain Loss On Note Conversions | 0001654954-25-005754 | Loss on note conversion | 1 |
0001654954-25-005754 | 6 | 12 | CF | 0 | H | Increase Decrease In Accounts Receivable | us-gaap/2024 | Accounts receivable | 1 |
0001654954-25-005754 | 6 | 13 | CF | 0 | H | Increase Decrease In Prepaid Expenses Other | us-gaap/2024 | Prepaid expenses and other | 1 |
0001654954-25-005754 | 6 | 14 | CF | 0 | H | Increase Decrease In Other Operating Assets | us-gaap/2024 | Other assets | 1 |
0001654954-25-005754 | 6 | 15 | CF | 0 | H | Increase Decrease In Operating Lease Liability | us-gaap/2024 | Operating lease liability | 0 |
0001654954-25-005754 | 6 | 16 | CF | 0 | H | Increase Decrease In Income Taxes Receivable | us-gaap/2024 | Payroll and income tax receivable | 1 |
0001654954-25-005754 | 6 | 17 | CF | 0 | H | Increase Decrease In Accounts Payable Trade | us-gaap/2024 | Accounts payable - trade and accrued expenses | 0 |
0001654954-25-005754 | 6 | 18 | CF | 0 | H | Increase Decrease In Deferred Revenue | us-gaap/2024 | Deferred revenue | 0 |
0001654954-25-005754 | 6 | 19 | CF | 0 | H | Net Cash Provided By Used In Operating Activities | us-gaap/2024 | NET CASH USED IN OPERATING ACTIVITIES | 0 |
0001654954-25-005754 | 6 | 21 | CF | 0 | H | Proceeds From Warrant Exercises | us-gaap/2024 | Proceeds from warrant exercise, net | 0 |
0001654954-25-005754 | 6 | 22 | CF | 0 | H | Repayments Of Related Party Debt | us-gaap/2024 | Repayment of advances from founders | 1 |
0001654954-25-005754 | 6 | 23 | CF | 0 | H | Proceeds From Stock Options Exercised | us-gaap/2024 | Proceeds from stock option exercises | 0 |
0001654954-25-005754 | 6 | 24 | CF | 0 | H | Net Cash Provided By Used In Financing Activities | us-gaap/2024 | NET CASH (USED IN) PROVIDED BY FINANCING ACTIVITIES | 0 |
0001654954-25-005754 | 6 | 25 | CF | 0 | H | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect | us-gaap/2024 | NET DECREASE IN CASH AND CASH EQUIVALENTS | 0 |
0001654954-25-005754 | 6 | 26 | CF | 0 | H | Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | us-gaap/2024 | Effect from exchange rate on cash | 0 |
0001654954-25-005754 | 6 | 27 | CF | 0 | H | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | us-gaap/2024 | CASH AND CASH EQUIVALENTS, beginning of period | 0 |
0001654954-25-005754 | 6 | 28 | CF | 0 | H | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | us-gaap/2024 | CASH AND CASH EQUIVALENTS, end of period | 0 |
0001654954-25-005754 | 6 | 30 | CF | 0 | H | Interest Paid Net | us-gaap/2024 | Interest paid | 0 |
0001654954-25-005754 | 6 | 31 | CF | 0 | H | Income Taxes Paid Net | us-gaap/2024 | Taxes paid | 0 |
0001654954-25-005754 | 6 | 33 | CF | 0 | H | Issuance Of Common Stock For Debt Conversion | 0001654954-25-005754 | Issuance of common stock for debt conversion | 0 |
0001654954-25-005754 | 6 | 34 | CF | 0 | H | Issuance Of Common Stock For Earnout Shares | 0001654954-25-005754 | Issuance of common stock for earnout shares | 0 |
0001654954-25-005754 | 6 | 35 | CF | 0 | H | Recognition Of Right Of Use Asset | 0001654954-25-005754 | Recognition of operating right-of-use asset | 0 |
0001654954-25-005754 | 6 | 36 | CF | 0 | H | Recognition Of Operating Lease Liability | 0001654954-25-005754 | Recognition of operating lease liability | 0 |
Field Name | Field Description |
---|---|
adsh | Accession Number. The 20-character string formed from the 18-digit number assigned by the SEC to each EDGAR submission. |
report | Represents the report grouping. This field corresponds to the statement (stmt) field, which indicates the type of statement. The numeric value refers to the “R file” as posted on the EDGAR Web site. |
line | Represents the tag’s presentation line order for a given report. Together with the statement and report field, presentation location, order and grouping can be derived. |
stmt | The financial statement location to which the value of the “report” field pertains. |
inpth | Value was presented “parenthetically” instead of in columns within the financial statements. For example: Receivables (net of allowance for bad debts of $200 in 2012) $700. |
rfile | The type of interactive data file rendered on the EDGAR web site, H = .htm file, X = .xml file. |
tag | The tag chosen by the filer for this line item. |
version | The taxonomy identifier if the tag is a standard tag, otherwise adsh. |
plabel | The text presented on the line item, also known as a “preferred” label. |
negating | Flag to indicate whether the plabel is negating. |